Virtual reality could be used to design new drugs, say researchers
Researchers have used virtual reality (VR) to control how drugs bind to their protein targets, which they say could be useful for designing new treatments.
List view / Grid view
Researchers have used virtual reality (VR) to control how drugs bind to their protein targets, which they say could be useful for designing new treatments.
Research into the M2 proton channel of influenza B has revealed its structure, which the team hope can aid in the development of targeted therapeutics to block the channel and treat the condition.
A study in mice has found that a compound modelled on a protein found in bananas safely protects against multiple strains of the influenza virus.
Researchers have developed a novel metal-based fragment library of molecules that can be used to screen for new drug candidates.
An mRNA vaccine has been developed which has elicited strong immune responses in mice in the presence of maternal antibodies.
A new double-layered nanoparticle vaccine protected mice against six strains of the flu and may provide the basis for the first universal vaccine against seasonal influenza, according to research.
Researchers have identified a set of three antibodies that they suggest could become the basis for a new antiviral treatment and inform the development of new influenza vaccines.
A new antiviral drug has been reported in a study that researchers believe has high clinical potential as a next-generation influenza drug.
Molecules that are critical for T cells to travel to and populate the lungs have been identified which could strengthen vaccines against influenza.
An international team of researchers has proven that targeting a specific area of the flu virus protects humans.
Findings from a recent study could lead to the development of therapeutic approaches against influenza A viruses.
Scientists have discovered an unexpected weakness in the influenza virus protein.
A recent study has uncovered a key mechanism that allows some of the world's deadliest viruses to replicate.
Scientists have detailed the role of a key controlling factor in the transformation of B-cells into antibody-secreting cells.
Osaka University researchers have developed a method using single-particle nanopore sensors and AI to detect single influenza virions...